It is time to drop use of the blue inhaler in adults and children over 12, a group of influential asthma experts have urged. There is now enough compelling evidence to use combined ICS–formoterol reliever therapy as an alternative to salbutamol inhalers, the clinicians from New Zealand and the UK write in a letter in ...
The time has come to end use of the blue inhaler: asthma experts
By Emma Wilkinson
13 May 2021